HARROW INC (HROW:NASDAQ)
$39.32 1.86 (4.9653%)
Analysed HARROW INC (HROW:NASDAQ) News Sources
What Does Cantor Fitzgerald Think About Harrow (HROW) After Cutting Its Price Target?
04-06-2026
yahoo.com
Harrow Re-Launches VERKAZIA® (cyclosporine ophthalmic emulsion) 0.1% for Vernal Keratoconjunctivitis, Addressing Significant Unmet Need in Pediatric Eyecare
10-06-2026
yahoo.com
Can Harrow’s (HROW) VERKAZIA Relaunch Redefine Its Niche Ophthalmic Strategy?
12-06-2026
yahoo.com
Is Harrow, Inc. (HROW) A Good Stock To Buy Now?
13-06-2026
yahoo.com
GROW Small Cap Equity Fund Covered Its Position in Harrow (HROW) in Q1
23-06-2026
yahoo.com
Samsung Bioepis Relaunches BYOOVIZ® (ranibizumab-nuna) in the United States in Partnership with Harrow
01-07-2026
yahoo.com
Harrow Announces Commercial Launch of BYOOVIZ® in the United States
01-07-2026
yahoo.com
Harrow Highlights Growing Clinical Evidence Supporting IHEEZO® and BYOOVIZ® at ASRS 2026 Annual Meeting
20-07-2026
yahoo.com
Samsung Bioepis and Harrow Present Interim Data from a Large-Scale Post-Marketing Surveillance Study on SB11 (BYOOVIZ® / AMELIVU®), a Biosimilar to Lucentis (ranibizumab), at ASRS 2026
20-07-2026
yahoo.com
Harrow To Report Second Quarter 2026 Financial Results After Market Close on August 10, 2026
27-07-2026
yahoo.com
What is the current price of HARROW INC (HROW:NASDAQ)?
The current price of HARROW INC (HROW:NASDAQ) is $39.32.
HARROW INC (HROW:NASDAQ) absolute price change since previous trading day?
The absolute price change of HARROW INC (HROW:NASDAQ) since the previous trading day is $1.86.
HARROW INC (HROW:NASDAQ) percentage price change since previous trading day?
The percentage price change of HARROW INC (HROW:NASDAQ) since the previous trading day is 4.9653%.
What is the most recent average sentiment score for HARROW INC (HROW:NASDAQ)?
The most recent average sentiment score for HARROW INC (HROW:NASDAQ) is 65 out of 100.
What is the most recent average sentiment for HARROW INC (HROW:NASDAQ)?
The most recent sentiment for HARROW INC (HROW:NASDAQ) is .
SEC-8K** Filing Available For HARROW INC (HROW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.